Brief: Chemomab Therapeutics Announces Expected Appointment Of Dale R. Pfost As Chairman
16/12/2021 21:12
Dec 16 (Reuters) - Chemomab Therapeutics Ltd CMMB.O :
* CHEMOMAB THERAPEUTICS ANNOUNCES EXPECTED APPOINTMENT OF
DALE R.
PFOST AS CHAIRMAN OF THE BOARD
Source text for Eikon: ID:nPn8bny5da
Further company coverage: CMMB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chemomab Therapeutics
See all newsBrief: Chemomab Therapeutics Announces Second Quarter 2026 Financial Results And Provides Corporate Update
Chemomab Therapeutics Ltd expected to post a loss of 15 cents a share - Earnings Preview
Israel's Chemomab Q4 net loss narrows on lower R&D spend
Brief: Chemomab Therapeutics Announces Nebokitug Phase 2 Spring Trial Results
Brief: Chemomab Therapeutics Announces Third Quarter 2025 Financial Results And Provides Corporate Update